Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
bovnews
4h
Analysts Predict a $62 Target for Halozyme Therapeutics, Inc. (HALO) Stock—What Could Drive It There?
On Friday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $49.25 which represents a decrease of $-0.05 or -0.10% from the prior close of $49.3. The stock opened at $49.35 ...
14h
Halozyme’s Patent Challenges and New Licensing Platform Lead to Hold Rating
Leerink Partners analyst David Risinger maintained a Hold rating on Halozyme (HALO – Research Report) yesterday and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grateful Dead bassist dies
Sentenced to over 50 years
Sentenced for Jan. 6 role
DNA tests identify skull
Apology for past US policy
Arlington incident report
Dismissal of charge upheld
Voter punches poll worker
NASA astronaut hospitalized
Jeffries pleads not guilty
Israel strikes back at Iran
Louisiana forces relocation
Hit w/ discrimination claims
CO ballots to be reexamined
Won't endorse candidates
MS late ballots count ruling
Murder-for-hire plot arrest
Strike kills 3 journalists
Approves Iterum's treatment
E. coli infections rise to 75
Madigan corruption trial
World's most valuable firm
Gaza peace talks to resume?
New student loan relief plan
Recalls chicken products
SC teen voting glitch
Joe Rogan hosts Trump
Seeks MI ballot exit
Delta sues CrowdStrike
VA voter roll purge blocked
Announces layoffs, jet sales
Favre to campaign w/ Trump
100+ dead in Philippines
'Spider-Man 4' set for '26
Feedback